These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35246523)

  • 1. Edonerpic maleate regulates glutamate receptors through CRMP2- and Arc-mediated mechanisms in response to brain trauma.
    Chen T; Yang LK; Ai P; Zhu J; Hang CH; Wang YH
    Cell Death Discov; 2022 Mar; 8(1):95. PubMed ID: 35246523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of edonerpic maleate as a CRMP2 inhibitor for pain relief.
    Moutal A; Shan Z; Miranda VG; François-Moutal L; Madura CL; Khanna M; Khanna R
    Channels (Austin); 2019 Dec; 13(1):498-504. PubMed ID: 31680630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRMP2-binding compound, edonerpic maleate, accelerates motor function recovery from brain damage.
    Abe H; Jitsuki S; Nakajima W; Murata Y; Jitsuki-Takahashi A; Katsuno Y; Tada H; Sano A; Suyama K; Mochizuki N; Komori T; Masuyama H; Okuda T; Goshima Y; Higo N; Takahashi T
    Science; 2018 Apr; 360(6384):50-57. PubMed ID: 29622647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mGluR5-mediated Arc activation protects against experimental traumatic brain injury in rats.
    Chen T; Li YF; Ren X; Wang YH
    CNS Neurosci Ther; 2024 Aug; 30(8):e14695. PubMed ID: 39107945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease: A Phase 2 Randomized Clinical Trial.
    Schneider LS; Thomas RG; Hendrix S; Rissman RA; Brewer JB; Salmon DP; Oltersdorf T; Okuda T; Feldman HH;
    JAMA Neurol; 2019 Nov; 76(11):1330-1339. PubMed ID: 31282954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arc silence aggravates traumatic neuronal injury via mGluR1-mediated ER stress and necroptosis.
    Chen T; Zhu J; Wang YH; Hang CH
    Cell Death Dis; 2020 Jan; 11(1):4. PubMed ID: 31919348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propofol ameliorates calpain-induced collapsin response mediator protein-2 proteolysis in traumatic brain injury in rats.
    Yu Y; Jian MY; Wang YZ; Han RQ
    Chin Med J (Engl); 2015 Apr; 128(7):919-27. PubMed ID: 25836613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CRMP2 binding compound accelerates functional recovery from central nervous system damage].
    Jitsuki S
    Nihon Yakurigaku Zasshi; 2022; 157(4):244-247. PubMed ID: 35781453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1/TLR4/NF-κB pathway following experimental traumatic brain injury.
    Chen X; Wu S; Chen C; Xie B; Fang Z; Hu W; Chen J; Fu H; He H
    J Neuroinflammation; 2017 Jul; 14(1):143. PubMed ID: 28738820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes derived from bone marrow mesenchymal stem cells attenuate neurological damage in traumatic brain injury by alleviating glutamate-mediated excitotoxicity.
    Zhuang Z; Liu M; Luo J; Zhang X; Dai Z; Zhang B; Chen H; Xue J; He M; Xu H; Liu A
    Exp Neurol; 2022 Nov; 357():114182. PubMed ID: 35901975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRMP2 improves memory deficits by enhancing the maturation of neuronal dendritic spines after traumatic brain injury.
    Sun YY; Zhu L; Sun ZL; Feng DF
    Exp Neurol; 2020 Jun; 328():113253. PubMed ID: 32084454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collapsin response mediator protein 2 (CRMP2) interacts with N-methyl-D-aspartate (NMDA) receptor and Na+/Ca2+ exchanger and regulates their functional activity.
    Brustovetsky T; Pellman JJ; Yang XF; Khanna R; Brustovetsky N
    J Biol Chem; 2014 Mar; 289(11):7470-82. PubMed ID: 24474686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of CRMP2 by Cdk5 Negatively Regulates the Surface Delivery and Synaptic Function of AMPA Receptors.
    Cheng L; Chen K; Li J; Wu J; Zhang J; Chen L; Guo G; Zhang J
    Mol Neurobiol; 2022 Feb; 59(2):762-777. PubMed ID: 34773219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CaMKII phosphorylates collapsin response mediator protein 2 and modulates axonal damage during glutamate excitotoxicity.
    Hou ST; Jiang SX; Aylsworth A; Ferguson G; Slinn J; Hu H; Leung T; Kappler J; Kaibuchi K
    J Neurochem; 2009 Nov; 111(3):870-81. PubMed ID: 19735446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aucubin alleviates oxidative stress and inflammation via Nrf2-mediated signaling activity in experimental traumatic brain injury.
    Wang H; Zhou XM; Wu LY; Liu GJ; Xu WD; Zhang XS; Gao YY; Tao T; Zhou Y; Lu Y; Wang J; Deng CL; Zhuang Z; Hang CH; Li W
    J Neuroinflammation; 2020 Jun; 17(1):188. PubMed ID: 32539839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Na(+)-K(+)-2Cl(-) Cotransporter-1 attenuates traumatic brain injury-induced neuronal apoptosis via regulation of Erk signaling.
    Hui H; Rao W; Zhang L; Xie Z; Peng C; Su N; Wang K; Wang L; Luo P; Hao YL; Zhang S; Fei Z
    Neurochem Int; 2016 Mar; 94():23-31. PubMed ID: 26854573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tat-collapsin response mediator protein 2 (CRMP2) increases the survival of neurons after NMDA excitotoxity by reducing the cleavage of CRMP2.
    Yin Y; Wang Y; Chen L; Han S; Zhao L; Luo Y; Li J
    Neurochem Res; 2013 Oct; 38(10):2095-104. PubMed ID: 23907512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel synaptic plasticity enhancer drug to augment functional recovery with rehabilitation.
    Takahashi T
    Curr Opin Neurol; 2019 Dec; 32(6):822-827. PubMed ID: 31567431
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.